Pure Global

Neoscreen hTSH EIA kit - India CDSCO Medical Device Registration

Neoscreen hTSH EIA kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000053_f984cebf81bda6608d23a8652123b8d2_ca2356d851866dd09345a206aabe0406. This device is marketed under the brand name Immunoreactive Tripsinogen. The license holder is Trivitron Healthcare Pvt. Ltd, and it is classified as Device Class Class C. The approving authority is Central Drug Standard Control Organisation, South Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Neoscreen hTSH EIA kit
UID: MFG/IVD/2020/000053_f984cebf81bda6608d23a8652123b8d2_ca2356d851866dd09345a206aabe0406

Brand Name

Immunoreactive Tripsinogen

Device Class

Class C

Approving Authority

Central Drug Standard Control Organisation, South Zone

Product Information

This Neoscreen hTSH EIA (Immunoreactive Tripsinogen) kit is for the quantitative determination of human thyrotropin (Immunoreactive Tripsinogen) in blood specimens dried on filter paper as a primary test for screening of babies for congenital hypothyroidism (Immunoreactive Tripsinogen). Monitoring of L-thyroxine replacement therapy can also be performed using this test, especially in cases when transportation of serum samples to the laboratory is difficult

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing